ID: ALA4100007

Max Phase: Preclinical

Molecular Formula: C14H21NO3S

Molecular Weight: 283.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(CC(C)C)ccc1CC(=O)NS(C)(=O)=O

Standard InChI:  InChI=1S/C14H21NO3S/c1-10(2)7-12-5-6-13(11(3)8-12)9-14(16)15-19(4,17)18/h5-6,8,10H,7,9H2,1-4H3,(H,15,16)

Standard InChI Key:  CQCGNEYZEKXMOP-UHFFFAOYSA-N

Associated Targets(Human)

Interleukin-8 receptors, CXCR1/CXCR2 285 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 283.39Molecular Weight (Monoisotopic): 283.1242AlogP: 1.81#Rotatable Bonds: 5
Polar Surface Area: 63.24Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.03CX Basic pKa: CX LogP: 2.49CX LogD: 1.55
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.90Np Likeness Score: -0.79

References

1. Liu YM, Nepali K, Liou JP..  (2017)  Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets.,  60  (2): [PMID:28122457] [10.1021/acs.jmedchem.6b00935]

Source